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Abstract- Normotensive hyperaldosteronism is a rare disorder. It is usually diagnosed with hypokalemia or 
an adrenal mass. Our patient was a 27-year-old female presented with weakness. She had normal blood 
pressure, hypokalemia, high plasma aldosterone level and suppressed plasma renin activity. After the saline 
load, test aldosterone didn’t show suppression. Adrenal computed tomography revealed a left adrenal mass. 
The patient was treated with spironolactone and potassium supplement. Surgical adrenalectomy was done. 
Final pathologic diagnosis was benign adrenocortical adenoma without capsular invasion. In postoperative 
course serum, potassium was normal. 
© 2015 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Primary hyperaldosteronism (PA) is the most 
common cause of secondary hypertension (1-3). The 
common form of primary aldosteronism is characterized 
by hypertension and hypokalemia. Although many cases 
with PA do not have hypokalemia (>50%), but 
normotensive patients are rare (1,4). It was first 
described by Brooks et al., in 1972 and reported patients 
are still rare (5). 
Unusual cases of normotensive PA are known by 
hypokalemia or by an incidentally discovered adrenal 
mass (6). The mechanisms underlying normal blood 
pressure are unknown. 
 
Case Report 
 
A 27-year-old female was admitted to our clinic 
because of muscle weakness since six months ago. She 
was examined by the local physician who diagnosed 
hypokalemia and admitted her to the hospital, then 
started KCL infusion. Familial history for hypertension 
was negative. 
At admission to our hospital, the body mass index 
was 22.8 kg/m2. Blood pressure values measured with a 
manual armlet were always below 110/80mmhg. Heart 
rate was 72 beats per minute and regular. Thyroid gland 
examination was normal. There was neither obesity nor 
hirsutism; neurological examination was normal. Other 
physical examinations were normal too. 
Renal function, urinary free cortisol, metanephrine, 
and normetanephrine were normal. 
As shown in Table 1, blood aldosterone levels were 
increased, and the plasma renin activity (PRA) was 
suppressed. 
 
 
Table1. Blood and urine aldosterone, and the PRA, 
 and Potassium levels 
Variable Adult Reference Range Patients 
3 months before admission   
Serum Potassium (meq/li) -- 2.4 
Aldosterone (pg/ml) 34-273 1131 
Plasma Renin activityActivity(ng/ml/hr) 4.4-41 <0.5 
On admission   
Aldosterone (pg/ml) 8-172 1377 
Plasma Renin Activity (ng/ml/hr) 0.5-1.9 <0.2 
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After infusion of 2liter 0.9% saline solution in 4h 
plasma, aldosterone was very high. Plain computed 
tomography image of the abdomen showed a mass 
measuring 3.2.2 cm in the body, and inner arm left 
adrenal gland (Arrow, Figure 1). 
 
 
Figure 1. CT scan of the adrenal gland, Arrow shows left adrenal 
mass. 
 
The patient then received 100 mg/day 
spironolactone and KCL infusion for 2 weeks 
before surgery, which normalized the serum 
potassium. 
The adrenal gland was surgically removed (Figure 
2), and the postoperative course was well. 
 
 
Figure 2. Macroscopic view of adrenal gland removed by surgery 
 
The macroscopic tumor consisted of one ovaloid 
piece of orange rubbery tissue with weight: 22gr, 
circumscribed mass: 2.8cm in diameter adjacent to 
adrenal tissue. 
In microscopic examination, it is reported as 
follow: Section of neoplastic tissue with the 
trabecular pattern was composed of cells with 
round nuclei, conspicuous nucleoli, and clear 
cytoplasm. Areas with nuclear atypia were seen. 
Necrosis, capsular invasion, and atypical mitosis 
were not present. Final pathologic diagnosis was 
benign adrenocortical adenoma without capsular 
invasion (Figure 3). 
 
 
Figure 3. Microscopic view of adrenal mass 
The patient had a normal serum potassium level 
without any medication or supplement. The mean 
level of blood pressure did not have any significant 
change compared to preoperative levels. She was 
good and had normal serum potassium four months 
after surgery.  
 
Discussion 
 
We described a patient with primary 
hyperaldosteronism presented with muscle weakness 
and normal blood pressure. Despite the absence of 
hypertension, hyperaldosteronism was confirmed by 
hypokalemia, suppressed PRA and increased plasma 
aldosterone levels. The patient had an adrenal mass on 
CT with a morphologically normal contralateral gland; 
histologic examination showed a typical adenoma with 
clear cells and normalization of hypokalemia after 
surgery. 
To best our knowledge 26 cases have been reported 
of which 55% were Asian, (Eurasians) especially 
Japanese and 67% were female. They were aged 
between 23 and 55 years. No familial cases were 
reported. Neuromuscular signs and symptoms (i.e. 
paresthesia, muscular weakness, and paralysis) were the 
main clinical characteristics.  
In another report about 10 normotensive PA one-
third of the hypertensive PA, patients had hypokalemia 
(5). This is consistent with the 10–40% prevalence 
observed in a large multicentre series of hypertensive 
PA (7).  
Different mechanisms leading to maintained normal 
blood pressure levels in primary aldosteronism have 
been described. Early diagnosis of hyperaldosteronism 
before the development of hypertension may be the 
cause in some patients. Salt restriction is mentioned as 
another cause (6). The negative findings in the salt 
loading test overrule the possibility that a low salt intake 
may have prevented the development of hypertension in 
our patient indeed; patients with normotensive primary 
aldosteronism may have a lower level of vasoconstrictor 
system or higher level of vasodilator system. High level 
of vasodilator system may result from increased 
secretion of vasodilator substances, such as 
prostaglandin E, kallikreins, and nitric oxide, or 
increased sensitivity to these substances (6).  
Another explanation could be that individuals with 
low normal ranges of blood pressure have wider 
intervals to reach defined values of hypertension. Thus, 
in hypertensive circumstances, like primary 
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aldosteronism, they may have increased blood pressure 
by more than 30 mmHg but be still in normal ranges and 
are considered normotensive (1). This is reported at least 
in one case with normotensive primary 
hyperaldosteronism, but our patient didn’t show a 
significant decrease in blood pressure after surgery.  
Lack of hypertension in hypokalemic patients should 
not exclude primary aldosteronism. 
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